Orthobiologics

Bone Therapeutics will not pursue U.S. clinical development of PREOB® autologous cell therapy. In the U.S., priority will be given...

DiscGenics announced allowance of 9 additional patents, including two in the U.S. and seven in EU markets. The company is...

TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource’s AlloFuse® Cortical Fibers and AlloFuse® Fiber...

Results from a study of AMNIOX Medical’s proprietary cryopreserved Amniotic Membrane as an adjunct to lumbar discectomy indicate improved outcomes in disability...

Histogenics has now enrolled ~3/4 of 245 patients required to complete enrollment of its ongoing NeoCart® Phase III clinical trial....

CollPlant received CE Mark approval for Vergenix™STR soft tissue repair matrix for the treatment of tendinopathy. EU launch is anticipated...

Lattice Biologics launched AmnioVisc™, a minimally-processed amniotic fluid supplement for the treatment of osteoarthritis pain in all joints....

Spineology received FDA 510(k) clearance for use of allograft bone with Rampart™ Interbody Fusion Devices....

Bone Therapeutics reported positive efficacy data from its Phase IIA trial of ALLOB® in spinal fusion....

Stryker Spine launched LITe® BIO, a hand-held bone graft material delivery device....